QT Imaging Holdings, Inc. (GigCapital5, Inc.) — Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022. The registrant was a special purpose acquisition company (SPAC), not an operating medical-imaging business. It had agreed to combine with QT Imaging, Inc.; the transaction was pending at the filing date. The filing was signed March 31, 2023.
Business context
GigCapital5 was formed to complete a business combination. On December 8, 2022, it entered into an agreement to merge with QT Imaging, a medical-device company developing and commercializing low-energy sound body-imaging systems. If completed, GigCapital5 would be renamed QT Imaging Holdings, Inc. and QT Imaging would become its wholly owned subsidiary. Closing remained subject to stockholder approval and other conditions; no PIPE subscription agreements were in place as of the filing date.
Financial results and liquidity
| Metric | FY 2022 / Dec. 31, 2022 | Prior period / Dec. 31, 2021 |
|---|---|---|
| Revenue | $0 | $0 |
| General and administrative expenses | $4.279 million | $1.081 million |
| Net loss | $2.774 million | $1.108 million |
| Trust-account interest income | $1.630 million | $5,978 |
| Cash outside trust | $78,196 | $421,549 |
| Cash and marketable securities in trust | $41.562 million | $232.304 million |
| Current assets | $250,704 | $1.162 million |
| Current liabilities | $4.186 million | $633,641 |
| Working capital | Deficit of $3.936 million | Not stated as a comparable figure |
The 2021 comparison covers January 19, 2021 (inception) through December 31, 2021, rather than a full fiscal year, so it is not directly comparable. Operating margins are not meaningful because the SPAC had no operating revenue. The 2022 net loss included $4.279 million of operating expenses and $486,615 of income-tax provision, partly offset by trust interest and $384,108 of other income, principally from changes in fair values of warrant and related-party note liabilities.
Operating activities used $1.262 million of cash in 2022. Investing activities provided $192.242 million, mainly reflecting trust funds withdrawn following redemptions; financing activities used $191.323 million, mainly for redemptions. At year-end, liabilities totaled $13.418 million, including a $9.2 million deferred underwriting fee payable, $640,000 principal on extension financing, and a working-capital note carried at fair value of $257,492. The company reported no long-term debt, lease obligations, or off-balance-sheet financing arrangements.
Material changes and subsequent events
- In September 2022, stockholders approved extensions and redeemed 18,985,950 public shares, about 82.5% of the IPO public shares; $192.138 million was withdrawn from the trust.
- After year-end, stockholders approved further extensions through September 28, 2023, in monthly increments funded by Sponsor deposits. In March 2023, they redeemed another 995,049 shares; approximately $10.450 million was withdrawn, leaving about $31.8 million in trust after the extension deposit.
- The Sponsor’s extension notes totaled $640,000 at year-end and increased to $1.060 million by March 28, 2023. Working-capital advances increased from $260,000 at year-end to $805,000 by the filing date; the Sponsor may elect to convert the note into units at $10 per unit.
- On March 20, 2023, Wells Fargo waived $6.440 million of deferred underwriting fees. The filing reported the original aggregate deferred fee as $9.2 million; verify the remaining amount and its treatment at closing.
Outlook, risks, and unusual items
The auditor highlighted substantial doubt about GigCapital5’s ability to continue as a going concern, citing no revenue, a $3.936 million working-capital deficit, limited cash outside trust, and dependence on completing a business combination. The financial statements include no adjustments for the outcome of this uncertainty. Management had no operating-business guidance or revenue outlook to provide.
Completion of the QT Imaging transaction was uncertain and depended on required approvals, regulatory and listing conditions, and other closing requirements. The company disclosed risks from further redemptions and limited transaction cash, inability to secure financing, dilution from merger shares, warrants and an 11% initial equity-plan pool, and potential liquidation if it failed to complete a transaction by the extended deadline. In a liquidation, public warrants would expire worthless; the filing estimated a possible redemption of approximately $10.37 per public share before certain claims and expenses.
Other notable risks include Sponsor and management conflicts of interest, the Sponsor’s voting control (about 68.3% of outstanding shares after the March 2023 redemptions), related-party financing and fees, creditor claims against trust funds, and the potential impact of macroeconomic and geopolitical conditions. The company reported effective disclosure controls and effective internal control over financial reporting as of year-end; the auditor did not express an opinion on internal control effectiveness.
Investor facts to verify
- Whether the business combination closed, its final terms and consideration, and the post-closing capital structure.
- Final redemption levels, cash available at closing, any PIPE or other financing, and remaining deferred underwriting fees.
- QT Imaging’s audited operating results, cash needs, existing debt and ability to commercialize its imaging systems; this SPAC filing does not provide a clear operating-performance picture for QT Imaging.
- The final impact of Sponsor loans, potential note conversion, earnout shares, warrants and equity-plan dilution.
- Whether the company met its extended business-combination deadline and, if not, the timing and amount of any liquidation distribution.